Researcher
Patrick Pauwels
- Research Expertise:molecular oncopathology
- Keywords:ANATOMOPATHOLOGY, ONCOLOGY, Medicine
- Disciplines:Oncology not elsewhere classified
- Research techniques:Next gen seq, ddPCR, liquid and tissue biopsy NGS, immunohistochemie, FISH, organoids
- Users of research expertise:researchers in de field of oncology
Affiliations
- Center for Oncological Research (CORE) (Research group)
Member
From1 Jan 2019 → Today - Molecular Imaging, Pathology, Radiotherapy & Oncology (MIPRO) (Research group)
Member
From1 Oct 2009 → 31 Dec 2018
Projects
1 - 10 of 30
- RNA Processing for anti-cancer immunotherapy (CANCERNA).From1 Jun 2022 → TodayFunding: Horizon Europe - Health
- Development of an innovative personalised CAR-NK cell therapy for pancreatic cancer.From1 Jan 2022 → TodayFunding: BOF - projects
- A novel photoelectrochemical detection technology for molecular cancer biomarkers.From1 Sep 2021 → 31 Oct 2022Funding: IOF - technology validation in lab
- Combining targeted therapy and immunotherapy to improve survival and quality of life of head and neck cancer patients.From1 Mar 2021 → TodayFunding: Nonprofit institution or equivalents
- Heterogeneity of HER2 amplification in breast cancer – the use of liquid biopsy to identify patients with discrepancies between primary tumor and metastatic lesionsFrom3 Mar 2020 → 2 Mar 2022Funding: Nonprofit institution or equivalents
- Urine as a liquid biopsy for early stage cancer detection.From1 Jan 2020 → TodayFunding: Baekeland
- Integrated Personalized & Precision Oncology Network (IPPON).From1 Jan 2020 → TodayFunding: BOF - research organisations, Fund Recuperation Fiscal Exemption
- Combined targeting of the epidermal growth factor receptor and the innate immune system: a novel therapeutic approach for the treatment of head and neck cancer.From1 Jan 2019 → TodayFunding: Nonprofit institution or equivalents
- Targeting CD70-positive cancer-associated fibroblasts to improve chemotherapy and alleviate the immuno-suppressive tumor microenvironment in advanced colorectal cancer.From1 Jan 2019 → 31 Dec 2022Funding: Nonprofit institution or equivalents
- Developing a novel synergistic approach of chemotherapy and immunotherapy to enhance the anti-tumor immune response in non-small cell lung cancer.From1 Oct 2018 → 30 Sep 2022Funding: BOF - Doctoral projects
Publications
1 - 10 of 228
- Expression of SARS-CoV-2-related surface proteins in non-small-cell lung cancer patients and the influence of standard of care therapy(2022)
Authors: Christophe Deben, Maxim Le Compte, Vasiliki Siozopoulou, Hilde Lambrechts, Christophe Hermans, Ho Wa Lau, Manon Huizing, Kevin Lamote, Jeroen Mh Hendriks, Peter Van Dam, et al.
Pages: 1 - 15 - PRECISION(2022)
Authors: J. Thouvenin, C. Van Marcke, L. Decoster, G. Raicevic, K. Punie, M. Vandenbulcke, R. Salgado, E. Van Valckenborgh, B. Maes, S. Joris, et al.
Pages: 1 - 8 - Prognostic factors and genetic markers in thymic epithelial tumors(2022)
Authors: Apostolos Agrafiotis, Vasiliki Siozopoulou, Jeroen Mh Hendriks, Patrick Pauwels, Senada Koljenovic, Paul Van Schil
Pages: 3242 - 3249 - The CD70-CD27 axis in oncology(2022)
Authors: Tal Flieswasser, Astrid Van den Eynde, Jonas Van Audenaerde, Jorrit De Waele, Filip Lardon, Carsten Riether, Hans de Haard, Evelien Smits, Patrick Pauwels, Julie Jacobs
- Diagnostic yield of genetic testing in heart transplant recipients with prior cardiomyopathy(2022)
Authors: Hanne Boen, Bart Loeys, Maaike Alaerts, Johan Saenen, Inge Goovaerts, Lutgart Van Laer, Anne Vorlat, Tom Vermeulen, Constantijn Franssen, Patrick Pauwels, et al.
Pages: 1218 - 1227 - A case report of a novel NTRK gene fusion in pleomorphic xanthoastrocytoma(2022)
Authors: Melek Ahmed, Joris Verlooy, An-Sofie Schoonjans, Sven Dekeyzer, Martin Lammens, Patrick Pauwels
Pages: 233 - 235 - Tumor microenvironment in thymic epithelial tumors(2022)
Authors: Apostolos Agrafiotis, Vasiliki Siozopoulou, Jeroen Mh Hendriks, Patrick Pauwels, Senada Koljenovic, Paul Van Schil
Pages: 1 - 11 - Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib(2022)
Authors: Ahmad Awada, Thierry Berghmans, Paul M. Clement, Kristof Cuppens, Bram De Wilde, Jean-Pascal Machiels, Patrick Pauwels, Marc Peeters, Sylvie Rottey, Eric Van Cutsem
- The use of pan-tropomyosin receptor kinase immunohistochemistry as a screening tool for the detection of neurotrophic tropomyosin-related kinase fusions(2022)
Authors: Mieke R. Van Bockstal, Gabriela Beniuga, Ligia Craciun, David Creytens, Franceska Dedeurwaerdere, Philippe Delvenne, Pieter Demetter, Bart De Wiest, Koen Dewinne, Lionel Habran, et al.
Pages: 393 - 406 - From macroscopy to ultrastructure(2022)
Authors: Peter Braubach, Christopher Werlein, Edith Plucinski, Mark P. Kuhnel, Annemiek Snoeckx, Tobias Welte, Axel Haverich, Florian P. Laenger, Sabine Dettmer, Patrick Pauwels, et al.
Pages: 1 - 7
Patents
1 - 2 of 2
- Immunotherapy Markers (Inventor)
- Immunotherapy markers (Inventor)